• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LncRNA SOX2-OT 是骨肉瘤患者的一种新型预后生物标志物,通过调节 SOX2 来调节骨肉瘤细胞的增殖和迁移。

LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.

机构信息

Department of Bone and Joint Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.

出版信息

IUBMB Life. 2017 Nov;69(11):867-876. doi: 10.1002/iub.1681. Epub 2017 Sep 29.

DOI:10.1002/iub.1681
PMID:28960757
Abstract

Long noncoding RNA (LncRNA) SOX2 overlapping transcript (SOX2-OT) has been shown to serve an oncogenic role in human lung cancer, hepatocellular carcinoma, and gastric cancer. However, the clinical significance and biological function of lncRNA SOX2-OT in osteosarcoma are still unclear. LncRNA SOX2-OT expression was measured in osteosarcoma tissues and cell lines. Loss-of-function and gain-of-function studies were performed to observe the effects of lncRNA SOX2-OT on osteosarcoma cells proliferation, migration, invasion, and expressions of cancer stem cell biomarker. The relationship between lncRNA SOX2-OT and SOX2 was analyzed in osteosarcoma tissues and cells. Rescued-function studies were conducted to confirm the role of SOX2 in the regulation of lncRNA SOX2-OT in osteosarcoma cells migration, invasion, and expression of cancer stem cell biomarkers. In our results, lncRNA SOX2-OT expression was increased in osteosarcoma tissues and cell lines, and associated with malignant status and overall survival in osteosarcoma patients. LncRNA SOX2-OT regulated osteosarcoma cells proliferation, migration, invasion, and expression of cancer stem cell biomarkers. LncRNA SOX2-OT positively regulated SOX2 expression in osteosarcoma cells and positively associated with SOX2 expression in osteosarcoma tissues. The rescued-function studies suggested that SOX2 is necessary for lncRNA SOX2-OT induced osteosarcoma cells migration, invasion, and expression of cancer stem cell biomarkers. In conclusion, lncRNA SOX2-OT is a prognostic biomarker for osteosarcoma patients and serves an oncogenic role to regulate osteosarcoma cells migration, invasion, and expression of cancer stem cell biomarkers. © 2017 IUBMB Life, 69(11):867-876, 2017.

摘要

长链非编码 RNA (LncRNA) SOX2 重叠转录物 (SOX2-OT) 已被证明在人类肺癌、肝细胞癌和胃癌中发挥致癌作用。然而,lncRNA SOX2-OT 在骨肉瘤中的临床意义和生物学功能仍不清楚。测量骨肉瘤组织和细胞系中的 lncRNA SOX2-OT 表达。进行功能丧失和功能获得研究,观察 lncRNA SOX2-OT 对骨肉瘤细胞增殖、迁移、侵袭和癌症干细胞标志物表达的影响。分析骨肉瘤组织和细胞中 lncRNA SOX2-OT 与 SOX2 的关系。进行挽救功能研究,以确认 SOX2 在调节骨肉瘤细胞迁移、侵袭和表达癌症干细胞标志物中的作用。在我们的研究结果中,lncRNA SOX2-OT 在骨肉瘤组织和细胞系中表达增加,与骨肉瘤患者的恶性状态和总生存相关。lncRNA SOX2-OT 调节骨肉瘤细胞增殖、迁移、侵袭和表达癌症干细胞标志物。lncRNA SOX2-OT 正向调节骨肉瘤细胞中的 SOX2 表达,并与骨肉瘤组织中的 SOX2 表达呈正相关。挽救功能研究表明,SOX2 是 lncRNA SOX2-OT 诱导的骨肉瘤细胞迁移、侵袭和表达癌症干细胞标志物所必需的。总之,lncRNA SOX2-OT 是骨肉瘤患者的预后生物标志物,发挥致癌作用,调节骨肉瘤细胞迁移、侵袭和表达癌症干细胞标志物。

相似文献

1
LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.LncRNA SOX2-OT 是骨肉瘤患者的一种新型预后生物标志物,通过调节 SOX2 来调节骨肉瘤细胞的增殖和迁移。
IUBMB Life. 2017 Nov;69(11):867-876. doi: 10.1002/iub.1681. Epub 2017 Sep 29.
2
IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling.IRF4 诱导的长链非编码 RNA SOX2-OT 通过调控 SOX2 和 PI3K/AKT 信号通路促进胆管癌细胞增殖和转移。
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8169-8178. doi: 10.26355/eurrev_201812_16509.
3
LncRNA SNHG20 is associated with clinical progression and enhances cell migration and invasion in osteosarcoma.长链非编码 RNA SNHG20 与临床进展相关,并增强骨肉瘤中的细胞迁移和侵袭。
IUBMB Life. 2018 Nov;70(11):1115-1121. doi: 10.1002/iub.1922. Epub 2018 Aug 18.
4
LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.LOXL1-AS1 预测骨肉瘤预后不良,并促进骨肉瘤细胞增殖、迁移和侵袭。
Biosci Rep. 2019 Apr 30;39(4). doi: 10.1042/BSR20190447.
5
LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression.长链非编码 RNA HIF2PUT 通过调节 HIF2 的表达抑制骨肉瘤干细胞的增殖、迁移和侵袭。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1342-1348. doi: 10.1080/21691401.2019.1596934.
6
Long noncoding RNA SOX2-OT facilitates prostate cancer cell proliferation and migration via miR-369-3p/CFL2 axis.长链非编码 RNA SOX2-OT 通过 miR-369-3p/CFL2 轴促进前列腺癌细胞的增殖和迁移。
Biochem Biophys Res Commun. 2019 Dec 10;520(3):586-593. doi: 10.1016/j.bbrc.2019.09.108. Epub 2019 Oct 14.
7
LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.长链非编码 RNA WWOX-AS1 抑制骨肉瘤细胞的增殖、迁移和侵袭。
Mol Med Rep. 2018 Jul;18(1):779-788. doi: 10.3892/mmr.2018.9058. Epub 2018 May 23.
8
MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.MALAT1预测骨肉瘤患者预后不良,并通过与EZH2结合促进细胞转移。
Oncotarget. 2017 Jul 18;8(29):46993-47006. doi: 10.18632/oncotarget.16551.
9
LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.长链非编码 RNA FAL1 是骨肉瘤的一种负预后生物标志物,并表现出致癌功能。
J Cell Biochem. 2018 Nov;119(10):8481-8489. doi: 10.1002/jcb.27074. Epub 2018 Jul 10.
10
Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.长链非编码 RNA CRNDE 作为骨肉瘤的诊断和预后生物标志物发挥作用,并且通过抑制 miR-335-3p 促进其进展。
J Biochem Mol Toxicol. 2021 May;35(5):e22734. doi: 10.1002/jbt.22734. Epub 2021 Feb 1.

引用本文的文献

1
Silencing long non-coding RNA linc00689 suppresses the growth and invasion of osteosarcoma cells by targeting miR-129-5p/NUSAP1.沉默长链非编码RNA linc00689通过靶向miR-129-5p/NUSAP1抑制骨肉瘤细胞的生长和侵袭。
Int J Exp Pathol. 2025 Mar;106(2):e12524. doi: 10.1111/iep.12524.
2
The emerging role of long non-coding RNA SOX2-OT in cancers and non-malignant diseases.长链非编码RNA SOX2-OT在癌症和非恶性疾病中的新作用。
J Physiol Biochem. 2025 Feb;81(1):57-83. doi: 10.1007/s13105-024-01059-2. Epub 2024 Dec 20.
3
AMPFLDAP: Adaptive Message Passing and Feature Fusion on Heterogeneous Network for LncRNA-Disease Associations Prediction.
AMPFLDAP:基于异构网络的自适应消息传递和特征融合的 lncRNA-疾病关联预测。
Interdiscip Sci. 2024 Sep;16(3):608-622. doi: 10.1007/s12539-024-00610-5. Epub 2024 Apr 6.
4
Emerging roles of long non-coding RNAs in osteosarcoma.长链非编码RNA在骨肉瘤中的新兴作用
Front Mol Biosci. 2024 Mar 7;11:1327459. doi: 10.3389/fmolb.2024.1327459. eCollection 2024.
5
Discovery of putative long non-coding RNAs expressed in the eyes of Astyanax mexicanus (Actinopterygii: Characidae).在墨西哥脂鲤(硬骨鱼纲:脂鲤科)眼睛中表达的假定长非编码 RNA 的发现。
Sci Rep. 2023 Jul 25;13(1):12051. doi: 10.1038/s41598-023-34198-5.
6
Cancer Stem Cells in Sarcomas: In Vitro Isolation and Role as Prognostic Markers: A Systematic Review.肉瘤中的癌症干细胞:体外分离及其作为预后标志物的作用:一项系统综述
Cancers (Basel). 2023 Apr 25;15(9):2449. doi: 10.3390/cancers15092449.
7
Crosstalk between Genes and Long Non-Coding RNAs in Glioblastoma.胶质母细胞瘤中基因与长非编码 RNA 的相互作用。
Int J Mol Sci. 2023 Mar 28;24(7):6392. doi: 10.3390/ijms24076392.
8
The Role of Tumor Microenvironment in Regulating the Plasticity of Osteosarcoma Cells.肿瘤微环境在调节骨肉瘤细胞可塑性中的作用。
Int J Mol Sci. 2022 Dec 18;23(24):16155. doi: 10.3390/ijms232416155.
9
Identification of genes contributing to cisplatin resistance in osteosarcoma cells.鉴定骨肉瘤细胞中顺铂耐药相关的基因。
FEBS Open Bio. 2023 Jan;13(1):164-173. doi: 10.1002/2211-5463.13524. Epub 2022 Nov 29.
10
Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis.聚焦尤文肉瘤发病机制中的长链非编码 RNA。
Cells. 2022 Apr 8;11(8):1267. doi: 10.3390/cells11081267.